Here, we posit a novel mechanism (Fig. 7) through which ICER could counteract resistance to MAPK inhibitors and potentially restore tumor sensitivity to therapy, though we also suspect similar mechanisms across a constellation of regulatory elements by ICER and other transcription factors contribute to this mechanism to fully inhibit melanoma progression. This evidence concerns the gene CREM and melanoma.